[1] Saha P, Modarai B, Humphries J,et al. The monocyte/macrophage as a therapeutic target in atherosclerosis[J]. Pharmacology, 2009, 9(2) :109-118. [2] van Gils JM, Zwaginga JJ, Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases[J]. J Leuk Biol, 2009, 85(2):195-204. [3] 费鲜明,周永列,祁金文,等. 木瓜蛋白酶体外对血小板聚集的抑制作用[J]. 中国临床药理学与治疗学,2009,14(8):906-911. [4] 蒋文雯,寇俊萍,张 红,等. 川芎嗪对脂多糖诱导的单核细胞组织因子表达的抑制作用[J]. 中国药科大学学报,2011,42(2):145-148. [5] Rains JL, Jain SK. Hyperketonemia increases monocyte adhesion to endothelial cells and is mediated by LFA-1 expression in monocytes and ICAM-1 expression in endothelial cells[J]. Am J Physiol Endocrinol Metab, 2011,301(2): E298-E306. [6] Schulz C, von Bruhl ML, Barocke V, et al. EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall[J]. J Thromb & Haemo, 2011,9(5):1007-1019. [7] Vigetti D, Genasetti A, Karousou E,et al. Proinflammatory cytokines induce hyaluronan synthesis and monocyte adhesion in human endothelial cells through hyaluronan synthase 2 (HAS2) and the nuclear factor- B(NF- B) pathway[J]. J Biol Chem, 2010,285(32): 24639-24645. [8] Quinn KL, Henriques M, Tabuchi A, et al. Human neutrophil peptides mediate endothelial-monocyte interaction, foam cell formation, and platelet activation[J]. Arterioscler Thromb Vasc Biol, 2011, 31(9):2070-2079. [9] 徐露,董志. 注射用羟基红花黄色素A对家兔血小板聚集、超微结构及血小板活化因子诱导后富血小板血浆中GMP-140含量的影响[J].中国临床药理学与治疗学,2012,17(3):269-273. [10]耿朝晖,郭竹英,胡晓波,等. 血小板活化标志物:血小板与单核细胞聚合物的临床应用[J]. 检验医学,2011,26(6):419-421. [11]Pillay J, Kamp VM, Pennings M, et al. Acute-phase concentrations of soluble fibrinogen inhibit neutrophil adhesion under flow conditions in vitro though interactions with ICAM-1(CD11b/CD18)[J]. J Thromb & Haemo, 2013, 11(6):1172-1182 . |